Back
ESC Professional Premium Access

Risks of antihypertensive treatment use in different periods of pregnancy

Session: Women's cardiovascular disease and pregnancy
Topic: Cardiovascular Disease in Women
Speaker: Professor J. Vaclavik (Ostrava, CZ)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Jan Vaclavik

University Hospital Ostrava, Ostrava (Czechia)
4 followers

6 more presentations in this session

Risk factors and prediction model for hypertension in women with hyperandrogenic phenotypes of polycystic ovary syndrome

Speaker: Doctor A. Stevanovic (Belgrade, RS)

Access
Abstract
Slides
Video
Like
Thumbnail

Empagliflozin significantly reduces the capacity of sera to induce endothelial dysfunction in Ischemia Non-Obstructive Coronary Arteries (INOCA): EMbArk phase II pilot trial

Speaker: Doctor O. Quesada (Cincinnati, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Sex differences in trajectory of left ventricular reverse remodelling under contemporary GDMT in recent-onset dilated cardiomyopathy

Speaker: Doctor Z. Yang (Sichuan, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Improving hypertension management in Egyptian women through standardised nurse training on blood pressure measurement

Speaker: Professor R. Hany Ibrahim (Cairo, EG)

Access
Abstract
Slides
Video
Like
Thumbnail

Exploring the relationship between testosterone and cardiovascular disease in women

Speaker: Doctor S. Alexander (Melbourne, AU)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Women's cardiovascular disease and pregnancy

Speakers: Professor J. Vaclavik, Doctor A. Stevanovic, Doctor O. Quesada, Doctor Z. Yang, Professor R. Hany Ibrahim...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources